SG Americas Securities’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.26M Sell
93,344
-122,975
-57% -$1.47M ﹤0.01% 1740
2026
Q1
$1.3M Sell
216,319
-59,767
-22% -$450K ﹤0.01% 1601
2025
Q4
$1.98M Buy
276,086
+117,962
+75% +$932K ﹤0.01% 1541
2025
Q3
$1.69M Buy
158,124
+108,507
+219% +$1.06M 0.01% 1049
2025
Q2
$480K Sell
49,617
-6,053
-11% -$62.4K ﹤0.01% 1707
2025
Q1
$829K Buy
+55,670
New +$856K ﹤0.01% 1330
2024
Q4
Sell
-22,689
Closed -$434K 3472
2024
Q3
$434K Buy
22,689
+14,000
+161% +$290K ﹤0.01% 1812
2024
Q2
$180K Buy
+8,689
New +$173K ﹤0.01% 2223
2024
Q1
Sell
-60,514
Closed -$873K 3291
2023
Q4
$873K Buy
60,514
+43,613
+258% +$593K 0.01% 1097
2023
Q3
$293K Sell
16,901
-53,388
-76% -$1.11M ﹤0.01% 2090
2023
Q2
$1.46M Buy
70,289
+56,150
+397% +$1.22M 0.01% 878
2023
Q1
$333K Buy
14,139
+5,908
+72% +$159K ﹤0.01% 2045
2022
Q4
$230K Sell
8,231
-5,355
-39% -$137K ﹤0.01% 2104
2022
Q3
$318K Buy
13,586
+6,208
+84% +$187K ﹤0.01% 1936
2022
Q2
$249K Sell
7,378
-30,525
-81% -$1.07M ﹤0.01% 2515
2022
Q1
$1.32M Buy
+37,903
New +$1.3M 0.01% 1224
2021
Q4
Sell
-8,828
Closed -$289K 3687
2021
Q3
$289K Sell
8,828
-91,970
-91% -$2.94M ﹤0.01% 2974
2021
Q2
$3.05M Buy
+100,798
New +$3.32M 0.01% 860

Other funds holding OGN

SG Americas Securities's OGN Position: Q2 2026 in Review

SG Americas Securities reduced its Organon & Co (OGN) stake by 57% in Q2 2026, selling an estimated $1.47M and leaving 93,344 shares worth $1.26M. The position accounts for ﹤0.01% of the portfolio, ranked #1740.

SG Americas Securities first reported a position in OGN in Q2 2021 and has held it in 18 quarters since. The position peaked at $3.05M in Q2 2021. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • SG Americas Securities held 93,344 shares of Organon & Co worth $1.26M as of Q2 2026.
  • SG Americas Securities sold 122,975 Organon & Co shares in Q2 2026, an estimated $1.47M.
  • Organon & Co made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #1740 holding.
  • SG Americas Securities first reported a position in Organon & Co in Q2 2021 and has held it in 18 quarters since.
  • SG Americas Securities's Organon & Co position peaked at $3.05M in Q2 2021.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.